more here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, February 26, 2015
However, Cowen said there are still “significant concerns” associated with prescribing separate estrogen and progesterone pills (non-compliance of the progesterone component can lead to increased risk for endometrial cancer), and therefore an U.S. Food and Drug Administration (FDA) approved combination of bioidentical estrogen and progesterone would be extremely well-received. “Additionally, with the passing of the Drug Quality and Security Act in 2013, compounding pharmacies will not be able to produce copies of TX-001HR once approved, suggesting that it could be the preferred product to capitalize on the $1.5 billion compounded hormone replacement therapy market opportunity,” said Cacciatore
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment